Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramiprosate open-label extension in Alzheimer's disease
NCT00314912Phase 3Unknown
- Sponsor
- GSK
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tramiprosate in Alzheimer's disease (AD), sponsored by GSK. Status: unknown.
02
Drugs
tramiprosate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00314912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314912.